Encompass Health Corporation $EHC Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lifted its position in shares of Encompass Health Corporation (NYSE:EHC) by 690.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 344,093 shares of the company’s stock after buying an additional 300,546 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.34% of Encompass Health worth $36,601,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Citizens National Bank Trust Department purchased a new position in Encompass Health during the third quarter worth about $26,000. First Horizon Corp purchased a new stake in shares of Encompass Health in the 3rd quarter valued at $34,000. Westside Investment Management Inc. raised its holdings in shares of Encompass Health by 56.7% in the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after buying an additional 101 shares during the period. Assetmark Inc. lifted its stake in Encompass Health by 88.1% during the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after acquiring an additional 140 shares in the last quarter. Finally, Root Financial Partners LLC purchased a new stake in Encompass Health during the third quarter worth about $39,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Buying and Selling at Encompass Health

In related news, CEO Mark J. Tarr sold 150,000 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total value of $16,746,000.00. Following the transaction, the chief executive officer directly owned 377,070 shares of the company’s stock, valued at $42,096,094.80. This trade represents a 28.46% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the sale, the treasurer directly owned 89,325 shares of the company’s stock, valued at $9,557,775. The trade was a 11.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 2.00% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC stock opened at $97.24 on Friday. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76. The firm has a fifty day moving average price of $102.39 and a 200 day moving average price of $110.51. The company has a market cap of $9.67 billion, a P/E ratio of 17.55, a PEG ratio of 1.87 and a beta of 0.75. Encompass Health Corporation has a 12 month low of $92.77 and a 12 month high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.29 by $0.17. The company had revenue of $3.09 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.Encompass Health’s quarterly revenue was up 9.9% on a year-over-year basis. During the same period last year, the firm earned $1.17 earnings per share. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Sell-side analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Wednesday, April 1st. Encompass Health’s payout ratio is currently 13.72%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on EHC shares. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Barclays upped their price objective on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a research report on Friday, February 6th. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of $143.29.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.